The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia

Pediatric Infectious Disease Journal

Volumn 28, Issue 9, 2009, Pages 761-765

  Jardine, Andrew ^a,b   Menzies, Robert I ^a   Deeks, Shelley L ^a   Patel, Mahomed S ^b   McIntyre, Peter B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Australian National University   (Australia)

Author keywords

Heptavalent pneumococcal conjugate vaccine; Immunization schedule; Middle ear ventilation; Otitis media

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; AUSTRALIA; CHILD; CHRONIC OTITIS MEDIA; DRUG DOSE REGIMEN; ELECTRONIC MEDICAL RECORD; HERD IMMUNITY; HUMAN; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MIDDLE EAR VENTILATION; MYRINGOTOMY; POISSON DISTRIBUTION; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVACCINATION; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIA;

EID: 68549107895     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31819e9bc5     Document Type: Article

References (36)

1. Bluestone CD. Role of surgery for otitis media in the era of resistant bacteria. Pediatr Infect Dis J. 1998;17:1090-1098.
2. Mattila P. Adenoidectomy and tympanostomy tubes in the management of otitis media. Curr Allergy Asthma Rep. 2006;6:321-326.
3. Block S. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J. 1997;16:449-456.
4. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-833.
5. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23:824-828.
6. National Health and Medical Research Council. The Australian Immunisation Handbook. 9th ed. Canberra, Australia: Australian Government Department of Health and Aging; 2008.
7. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-16.
8. Palmu AA, Verho J, Jokinen J, et al. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J. 2004;23:732-738.
9. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007;119:707-715.
10. National Centre for Classification in Health. International Classification of Diseases, 10th Revision, Australian Modification (ICD-10-AM). 2nd ed. Sydney, Australia: National Centre for Classification in Health; 2000.
11. Gunasekera H, Knox S, Morris P, et al. The spectrum and management of otitis media in Australian indigenous and nonindigenous children: a national study. Pediatr Infect Dis J. 2007;26:689-692.
12. Gibney KB, Morris PS, Carapetis JR, et al. The clinical course of acute otitis media in high-risk Australian Aboriginal children: a longitudinal study. BMC Pediatr. 2005-2006;5:16.
13. Leach AJ. Otitis media in Australian Aboriginal children: an overview. Int J Pediatr Otorhinolaryngol. 199;49(suppl 1):S173-S178.
14. Australian Institute of Health and Welfare. Improving the Quality of Indigenous Identification in Hospital Separations Data. Canberra, Australia: AIHW; 2005. AIHW cat. no. HSE 101. Health Services Series no. 25.
15. Menzies R, Turnour C, Chiu C, et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell. 2008;32(suppl):S2-S67.
16. Lopalco P; Editorial team. Use of 7-valent pneumococcal conjugate vaccine in EU. Euro Surveill. 2006;11:pii = 3092. Available at: http://www.eurosurveil- lance.org/ViewArticle.aspx?ArticleId=3092. Accessed June 19, 2008.
17. Committee on Infectious Diseases. Recommended immunization schedules for children and adolescents-United States, 2007. Pediatrics. 2007; 119: 207-208
18. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunoge-nicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
19. Mahon BE, Hsu K, Karumuri S, et al. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine. 2006;24:2514-2520.
20. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368:1495-1502.
21. Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunoge-nicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics. 1998;101:604-611.
22. Pelton SI, Dagan R, Gaines BM, et al. Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Vaccine. 2003;21:1562-1571.
23. Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to naso-pharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192:387-393. (Pubitemid 41023116)
24. Millar EV, O?Brien KL, Bronsdon MA, et al. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1173-1179.
25. Jokinen JT, Ahman H, Kilpi TM, et al. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. J Infect Dis. 2004;190:545-550.
26. Pichichero ME, Casey JR. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 2007;26(suppl 10):S12-S16.
27. Roche PW, Krause V, Cook H, et al. Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell. 2008;32:18-30.
28. Zhou FJ, Shefer A, Kong Y, et al. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008;121:253-260.
29. Grijalva CG, Poehling KA, Nuorti JP, et al. National Impact of universal childhood immunization with pneumococcal conjugate vaccine on out-patient medical care visits in the United States. Pediatrics. 2006;118:865-873.
30. Spilsbury K, Kadhim AL, Semmens JB, et al. Decreasing rates of middle ear surgery in Western Australian children. Arch Otolaryngol Head Neck Surg. 2006;132:1216-1220.
31. Keyhani S, Kleinman LC, Rothschild M, et al. Overuse of tympanostomy tubes in New York metropolitan area: evidence from five hospital cohort. BMJ. 2008;337:a1607.
32. Rob MI, Westbrook JI, Taylor R, et al. Increased rates of ENT surgery among young children: have clinical guidelines made a difference? J Paediatr Child Health. 2004;40:627-632.
33. Lous J, Burton MJ, Felding JU, et al. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Co-chrane Database Syst Rev. 2005:CD001801.
34. Paradise JL, Feldman HM, Campbell TF, et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med. 2001;344:1179-1187.
35. Rovers MM, Straatman H, Ingels K, et al. The effect of ventilation tubes on language development in infants with otitis media with effusion: a randomized trial. Pediatrics. 2000;106:E42. Australian Bureau of Statistics (ABS). Child Care Australia. Canberra, Australia: ABS; 2005. Report 4402.0.
36. Rovers MM, de Kok IM, Schilder AG. Risk factors for otitis media: an international perspective. Int J Pediatr Otorhinolaryngol. 2006;70: 1251-1256.